HepVu

An estimated 3.5 million people in the U.S. are living with chronic Hepatitis C infection.

Beyond the Map

Learn more about the Hepatitis B and Hepatitis C epidemics in the United States.

View Local Data

Learn more about Hepatitis C where you live with state-specific statistics and national and regional comparison charts.

Deeper Look: Opioids

Take a deeper look at how the ongoing opioid crisis impacts the Hepatitis C epidemic in the U.S.

Hepatitis ABCs

Know the difference between Hepatitis A, B, and C? Learn the facts, symptoms, and who’s at risk for each disease here.

View the Map

HepVu News & Updates

Stay up to date with new data, maps, infographics, blog posts, and other educational resources to help you better understand the Hepatitis B and Hepatitis C epidemics in the United States and their intersection with the opioid epidemic.

View News & Updates
Prev-Black-500x500

News & Updates

HepVu Launches New Data Visualizing Hepatitis C’s Impact on Americans of Different Ages, Sexes, and Races

Research From Georgia State, Emory, CDC, and UAlbany Illustrate Disparities in Hepatitis C Infections in Communities Across the U.S.

Learn More
193779_web-1

Vu Q&A

Vu Q&A: Dr. Heather Bradley on Hep C by Race, Sex, and Age

Heather Bradley, PhD, Assistant Professor of Epidemiology at Georgia State University and HepVu Project Director, discusses how the Hepatitis C epidemic continues to disproportionately impact certain populations and areas of the country.

Learn More
pNROzfFy

News & Updates

A Year in Review: HepVu’s 2019 Highlights

As 2019 draws to a close, HepVu takes a look back at this year's highlights – from our most-shared infographics to new data to insightful Q&As with viral hepatitis and opioid experts.

Learn More
Monica

Vu Q&A

Vu Q&A: Monica Graybeal on Ending Hep C in Washington State

Dr. Monica Graybeal, PharmD, Hepatitis C ambulatory and community pharmacist at Yakima Valley Farm Workers Clinic and an adjunct professor at Washington State University, talks about ending Hepatitis C in Washington state.

Learn More
Ward_John-1

Vu Q&A

Vu Q&A: Dr. John Ward on Global Hepatitis Elimination

Dr. John Ward discusses the Coalition for Global Hepatitis Elimination and how to to help prevent viral hepatitis outbreaks and work towards eliminating Hepatitis B and C.

Learn More
f

Vu Q&A

Vu Q&A: Sonia Canzater and Jeff Crowley on Hepatitis C and the Ryan White HIV/AIDS Program

Sonia Canzater and Jeff Crowley talk about their new brief, “Eliminating Hepatitis C Among People Living With HIV in the United States: Leveraging the Ryan White HIV/AIDS Program to Move Us Forward.”

Learn More
Rose_Michelle_NMG

Vu Q&A

Vu Q&A: Michelle Rose on Perinatal Hepatitis C Transmission in Kentucky

Michelle Rose, the Population Health Manager for Norton Healthcare in Kentucky, explains how testing pregnant women for Hepatitis C in Kentucky is helping reduce perinatal transmission.

Learn More
SOnofreyPic

Vu Q&A

Vu Q&A: Shauna Onofrey on Hepatitis C Elimination Efforts in Massachusetts

Shauna Onofrey, an epidemiologist at the Massachusetts Department of Public Health, speaks about what Massachusetts is doing to eliminate Hepatitis C.

Learn More
03 copy

Awareness Days

Hepatitis Testing Day 2019

Approximately 2.3 million people are living with Hepatitis C and between 850,000 and 2.2 million people are living with Hepatitis B in the U.S.

Learn More
bufOXvk8

Vu Q&A

Vu Q&A: Guillermo Chacón on Hepatitis among Hispanics/Latinx

Guillermo Chacón, President of the Latino Commission on AIDS, shares the history of National Hispanic Hepatitis Awareness Day, or NHHAD (May 15), and what the Commission is doing to raise awareness about the impact of viral hepatitis on Latinx communities.

Learn More
Headshot - Lindey Dawson

Vu Q&A

Vu Q&A: Lindsey Dawson on Hepatitis C, HIV, and Health Insurance

Lindsey Dawson, MPP, Associate Director of HIV Policy at the Kaiser Family Foundation, speaks about the impact health insurance generally and Medicaid expansion specifically have had on Hepatitis C and HIV.

Learn More
03-HepVu-Opioid-Homepage-04

Hep C

HepVu Releases New State-Level Maps Showing Impact of Hepatitis C in the U.S.

New data show where Hepatitis C is hitting states hardest. Read on to learn more about the new 2013-2016 estimates and download shareable infographics.

Learn More
01-HepVu-Opioid-Homepage-01

Opioids

Vu Q&A: The Opioid Epidemic’s Impact on Hepatitis C in the U.S.

Heather Bradley, Ph.D., Georgia State University, and Ron Valdiserri, M.D., MPH, Johns Hopkins University, share their expert insights on the intersection of the opioid and Hepatitis C epidemics.

Learn More
Don-Des-Jarlais

Opioids

Addressing Increases in Hepatitis C Infections Linked to the Opioid Epidemic

The other important component of the U.S. Hepatitis C epidemic is smaller in absolute numbers but is the major source of new Hepatitis C infections: infections associated with the opioid epidemic, injection drug use, and the sharing of needles and other drug injection equipment.

Learn More
Galbraith_J

Vu Q&A

Vu Q&A: Testing Vulnerable Populations in the Emergency Room

Dr. James Galbraith talks about the importance of testing in the Emergency Room.

Learn More
Kate-Moraras-blog-300x300

Vu Q&A

Vu Q&A: Using Storytelling to Reduce Hepatitis B Stigma

Kate Moraras, Senior Program Director at the Hepatitis B Foundation and the Director of Hep B United, talks about how to reduce Hep B stigma.

Learn More

Sign up for HepVu updates: